Matrix Metalloproteinase-3 in Myasthenia Gravis Compared to Other Neurological Disorders and Healthy Controls

Table 1

MMP-3 concentrations (ng/mL) in patients with neurological disorders and healthy controls.

	MG	MS	Epilepsy	Stroke	Healthy controls
Number of patients	124	59	74	33	90
Mean MMP-3 concentration	25.5 (±27.4)	16.6 (±23.9)	19.4 (±16.4)	11.7 (±8.1)	23.4 (±12.3)
Number of MMP-3-positives	19 (15.3%)	2 (3.4%)	5 (6.7%)	0	4 (4.4%)
Mean MMP-3 concentration of MMP-3-positives	79.9 (±27.9)	116.5 (±89.8)	67.0 (±21.2)	0	54.0 (±3.6)